{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:20:21Z","timestamp":1788326421439,"version":"build-2803163510"},"reference-count":12,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Council for Pediatric Advanced Therapy and the Tokyo Health Service Association"},{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau","doi-asserted-by":"crossref","award":["JH2024-B-07"],"award-info":[{"award-number":["JH2024-B-07"]}],"id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health Labour and Welfare","award":["JPMH24FC1010"],"award-info":[{"award-number":["JPMH24FC1010"]}]},{"award":["JPMH24FC1010"],"award-info":[{"award-number":["JPMH24FC1010"]}],"id":[{"id":"https:\/\/ror.org\/03mwa7s65","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Neonatal Screen.","IJNS"],"abstract":"<jats:p>Newborn screening (NBS) facilitates the presymptomatic diagnosis and early treatment of spinal muscular atrophy (SMA). An analytical study was conducted to evaluate the performance and limitations of a real-time polymerase chain reaction-based SMA-NBS assay. Dried blood spot specimens collected from 21 newborns and three patients with genetically confirmed SMA were analyzed. The SMA controls included two patients with homozygous SMN1 deletion and one with compound heterozygous SMN1 variants. SMN1 exon 7 copy numbers were quantified and interpreted. All newborn participants had SMN1 copy numbers above the screening cutoff value of 668 copies\/\u00b5L and were classified as screening-negative. The two SMA controls with homozygous SMN1 deletion showed no detectable SMN1 amplification, which is consistent with positive screening results. In contrast, the compound heterozygous SMA control exhibited a mean SMN1 value of 7330 copies\/\u00b5L, which was more than tenfold above the screening cutoff and would therefore have been classified as screening-negative; this value also fell within the range observed in the newborn cohort. This patient had a negative NBS result at birth despite subsequently developing genetically confirmed SMA. The SMA-NBS assay accurately detected patients with homozygous SMN1 deletion. However, it did not identify patients with compound heterozygous SMN1 variants. In conclusion, deletion-based SMA-NBS has an inherent false-negative limitation, and a negative screening result does not completely exclude an SMA diagnosis.<\/jats:p>","DOI":"10.3390\/ijns12030071","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:45:13Z","timestamp":1788241513000},"page":"71","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analytical Study Showing a False-Negative Limitation of Deletion-Based Newborn Screening for Spinal Muscular Atrophy Using a Compound Heterozygous SMN1 Control"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-0029","authenticated-orcid":false,"given":"Yuichi","family":"Abe","sequence":"first","affiliation":[{"name":"Division of Neurology, National Center for Child Health and Development, Tokyo 157-8535, Japan"},{"name":"Center for Genetic Medicine, National Center for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Sato","family":"Suzuki-Muromoto","sequence":"additional","affiliation":[{"name":"Division of Neurology, National Center for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Motomichi","family":"Kosuga","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine, National Center for Child Health and Development, Tokyo 157-8535, Japan"},{"name":"Division of Medical Genetics, National Center for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Tetsuya","family":"Isayama","sequence":"additional","affiliation":[{"name":"Division of Neonatology, National Center for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-0748","authenticated-orcid":false,"given":"Go","family":"Tajima","sequence":"additional","affiliation":[{"name":"Division of Neonatal Screening, Research Institute, National Center for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Yasuhito","family":"Aoki","sequence":"additional","affiliation":[{"name":"Diagnostics Division, Sekisui Medical Co., Ltd., Tokyo 103-0027, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-2705","authenticated-orcid":false,"given":"Nobuyuki","family":"Ishige","sequence":"additional","affiliation":[{"name":"Division of Newborn Screening, Tokyo Health Service Association, Tokyo 162-0842, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Yushi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Neonatology, National Center for Child Health and Development, Tokyo 157-8535, Japan"},{"name":"Department of Neonatology, Sanno Hospital, Tokyo 107-0052, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy: A literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Angilletta, I., Ferrante, R., Giansante, R., Lombardi, L., Babore, A., Dell\u2019Elice, A., Alessandrelli, E., Notarangelo, S., Ranaudo, M., and Palmarini, C. (2023). Spinal muscular atrophy: An evolving scenario through new perspectives in diagnosis and advances in therapies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914873"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kimizu, T., Ida, S., Okamoto, K., Awano, H., Niba, E.T.E., Wijaya, Y.O.S., Okazaki, S., Shimomura, H., Lee, T., and Tominaga, K. (2021). Spinal muscular atrophy: Diagnosis, incidence, and newborn screening in Japan. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7030045"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","article-title":"Spinal muscular atrophy: In the challenge lies a solution","volume":"44","author":"Wirth","year":"2021","journal-title":"Trends Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Day, J.W., Howell, K., Place, A., Long, K., Rossello, J., Kertesz, N., and Nomikos, G. (2022). Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatr., 22.","DOI":"10.1186\/s12887-022-03671-x"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11940-019-0568-z","article-title":"Current treatment options in neurology\u2014SMA therapeutics","volume":"21","author":"Waldrop","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_8","unstructured":"Sekisui Medical Co., Ltd. (2026, June 12). NeoSMAAT\u00ae T\/K\/S Instructions for Use. Available online: https:\/\/www.sekisuimedical.jp\/check.html?url=\/business\/diagnostics\/others\/neosmaat_tks\/operate.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100066","DOI":"10.1016\/j.bdcasr.2025.100066","article-title":"A case of severe spinal muscular atrophy type 1 resistant to specific treatment due to a missense variant in the Tudor domain of SMN1","volume":"3","author":"Aihara","year":"2025","journal-title":"Brain Dev. Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.gim.0000227970.60450.b2","article-title":"A feasibility study for the newborn screening of spinal muscular atrophy","volume":"8","author":"Pyatt","year":"2006","journal-title":"Genet. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cooper, K., Nalbant, G., Sutton, A., Harnan, S., Thokala, P., Chilcott, J., McNeill, A., and Bessey, A. (2024). Systematic review of newborn screening programmes for spinal muscular atrophy. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10030049"},{"key":"ref_12","first-page":"e42382","article-title":"Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A case report","volume":"15","author":"Hashimoto","year":"2023","journal-title":"Cureus"}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/3\/71\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:32:32Z","timestamp":1788323552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/3\/71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijns12030071"],"URL":"https:\/\/doi.org\/10.3390\/ijns12030071","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}